@article{radzina_novel_2023,
	title = {Novel radionuclides for use in {Nuclear} {Medicine} in {Europe}: where do we stand and where do we go?},
	volume = {8},
	issn = {2365-421X},
	shorttitle = {Novel radionuclides for use in {Nuclear} {Medicine} in {Europe}},
	url = {https://ejnmmipharmchem.springeropen.com/articles/10.1186/s41181-023-00211-5},
	doi = {10.1186/s41181-023-00211-5},
	abstract = {Abstract
            
              Background
              In order to support the ongoing research across Europe to facilitate access to novel radionuclides, the PRISMAP consortium (European medical radionuclides programme) was established to offer the broadest catalog of non-conventional radionuclides for medical and translational research. The aim of this article is to introduce readers with current status of novel radionuclides in Europe.
            
            
              Main body
              
                A consortium questionnaire was disseminated through the PRISMAP consortium and user community, professional associations and preclinical/clinical end users in Europe and the current status of clinical end-users in nuclear medicine were identified. A total of 40 preclinical/clinical users institutions took part in the survey. Clinical end users currently use the following radionuclides in their studies:
                177
                Lu,
                68
                 Ga,
                111
                In,
                90
                Y, other alpha emitters,
                225
                Ac,
                64
                Cu and Terbium isotopes. Radionuclides that would be of interest for users within the next 2–5 years are
                64
                Cu, Terbium radionuclide “family” and alpha emitters, such as
                225
                Ac.
              
            
            
              Conclusions
              Thanks to a questionnaire distributed by the PRISMAP consortium, the current status and needs of clinical end-users in nuclear medicine were identified.},
	language = {en},
	number = {1},
	urldate = {2023-11-16},
	journal = {EJNMMI Radiopharmacy and Chemistry},
	author = {Radzina, Maija and Saule, Laura and Mamis, Edgars and Koester, Ulli and Cocolios, Thomas Elias and Pajuste, Elina and Kalnina, Marika and Palskis, Kristaps and Sawitzki, Zoe and Talip, Zeynep and Jensen, Mikael and Duchemin, Charlotte and Leufgen, Kirsten and Stora, Thierry},
	month = oct,
	year = {2023},
	keywords = {scientific-publication},
	pages = {27},
}